Literature DB >> 2783977

Congenital generalised bone dysplasias: a clinical, radiological, and epidemiological survey.

P E Andersen1, M Hauge.   

Abstract

The point prevalence at birth of generalised bone dysplasias was estimated by a study of all children born between 1 January 1970 and 31 December 1983 in the county of Fyn (Denmark). Additionally the population prevalence on 31 December 1983 of all patients with generalised bone dysplasias in this county was determined. The county is a well defined, representative subregion of Denmark which demographically comprises a cross section of about 9% of the Danish population. In total, bone dysplasias were found to be more frequent than generally assumed. Achondroplasia was, however, less common with a point prevalence at birth of 1.3 per 100,000, while osteogenesis imperfecta (21.8), multiple epiphyseal dysplasia tarda (9.0), achondrogenesis (6.4), osteopetrosis (5.1), and thanatophoric dysplasia (3.8) were found more frequently. It is striking how many bone dysplasias are still erroneously classified as achondroplasia. Correct diagnosis is important for a valid prognosis, for treatment, and for genetic counselling. The diagnosis relies almost exclusively on the radiographical findings.

Entities:  

Mesh:

Year:  1989        PMID: 2783977      PMCID: PMC1015534          DOI: 10.1136/jmg.26.1.37

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  13 in total

Review 1.  Osteopetrosis. A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form.

Authors:  C C Johnston; N Lavy; T Lord; F Vellios; A D Merritt; W P Deiss
Journal:  Medicine (Baltimore)       Date:  1968-03       Impact factor: 1.889

2.  Achondrogenesis type II in twins.

Authors:  P E Andersen
Journal:  Br J Radiol       Date:  1981-01       Impact factor: 3.039

3.  Cloverleaf skull with generalised bone dysplasia. Report of a case with short review of the literature.

Authors:  K Kozlowski; P S Warren; C C Fisher
Journal:  Pediatr Radiol       Date:  1985

4.  Genetic heterogeneity in osteogenesis imperfecta.

Authors:  D O Sillence; A Senn; D M Danks
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

5.  The birth prevalence rates for the skeletal dysplasias.

Authors:  I M Orioli; E E Castilla; J G Barbosa-Neto
Journal:  J Med Genet       Date:  1986-08       Impact factor: 6.318

6.  Osteogenesis imperfecta: an expanding panorama of variants.

Authors:  D Sillence
Journal:  Clin Orthop Relat Res       Date:  1981-09       Impact factor: 4.176

7.  Chondrodysplasia punctata. Report of two cases.

Authors:  P E Andersen; P Justesen
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

8.  Heterogeneity of autosomal dominant osteopetrosis.

Authors:  P E Andersen; J Bollerslev
Journal:  Radiology       Date:  1987-07       Impact factor: 11.105

9.  The prevalence of skeletal dysplasias. An estimate of their minimum frequency and the number of patients requiring orthopaedic care.

Authors:  R Wynne-Davies; J Gormley
Journal:  J Bone Joint Surg Br       Date:  1985-01

10.  Bilateral failure of the capital femoral epiphysis: bilateral Perthes disease, multiple epiphyseal dysplasia, pseudoachondroplasia, and spondyloepiphyseal dysplasia congenita and tarda.

Authors:  J F Crossan; R Wynne-Davies; G E Fulford
Journal:  J Pediatr Orthop       Date:  1983-07       Impact factor: 2.324

View more
  18 in total

1.  Poul Erik Andersen's radiological work on Osteochondrodysplasias and interventional radiology.

Authors:  Poul Erik Andersen
Journal:  World J Radiol       Date:  2011-08-28

2.  A report of an Indian boy with a delayed diagnosis of pseudochondroplasia.

Authors:  Ankur Singh; T Abiramalatha; Gaurav Pradhan; Dong-Kyu Jin; Seema Kapoor
Journal:  J Clin Diagn Res       Date:  2013-07-01

3.  Standard method of diagnosis versus use of a computer database in the evaluation of skeletal dysplasias.

Authors:  R K Harned; L E Patrick; B B Gay; G O Atkinson; P K Niemer; J B Wyly; W S Clark
Journal:  Pediatr Radiol       Date:  1996-12

4.  Reliability of lower-limb alignment measurements in patients with multiple epiphyseal dysplasia.

Authors:  Bekhzad Akhmedov; Ki Hyuk Sung; Chin Youb Chung; Kyoung Min Lee; Moon Seok Park
Journal:  Clin Orthop Relat Res       Date:  2012-09-05       Impact factor: 4.176

Review 5.  Skeletal dysplasias: A radiographic approach and review of common non-lethal skeletal dysplasias.

Authors:  Ananya Panda; Shivanand Gamanagatti; Manisha Jana; Arun Kumar Gupta
Journal:  World J Radiol       Date:  2014-10-28

6.  Quantitative approach to the posterior cranial fossa and craniocervical junction in asymptomatic children with achondroplasia.

Authors:  Rosalinda Calandrelli; Marco Panfili; Gabriella D'Apolito; Giuseppe Zampino; Alessandro Pedicelli; Fabio Pilato; Cesare Colosimo
Journal:  Neuroradiology       Date:  2017-08-17       Impact factor: 2.804

7.  Modyfied wedge osteotomy for osteoarthritis of elbow secondary to osteochondritis dissecans in adolecent with multiple epiphyseal dysplasia. A case report.

Authors:  Takashi Yoshida; Wook-Cheol Kim; Yoshinobu Oka; Masashi Nakase; Atsushi Nishida; Hiroaki Wada; Yuji Arai; Toshikazu Kubo
Journal:  J Orthop       Date:  2017-08-10

8.  The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US.

Authors:  D K Waller; A Correa; Tuan M Vo; Y Wang; C Hobbs; P H Langlois; K Pearson; P A Romitti; G M Shaw; J T Hecht
Journal:  Am J Med Genet A       Date:  2008-09-15       Impact factor: 2.802

9.  Achondroplasia is defined by recurrent G380R mutations of FGFR3.

Authors:  G A Bellus; T W Hefferon; R I Ortiz de Luna; J T Hecht; W A Horton; M Machado; I Kaitila; I McIntosh; C A Francomano
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

10.  Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.

Authors:  M K Webster; D J Donoghue
Journal:  EMBO J       Date:  1996-02-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.